Elbow Hemiarthroplasty Versus ORIF for Distal Humeral Fractures
1 other identifier
interventional
44
1 country
1
Brief Summary
This is a randomized control trial comparing the outcome of ORIF (open reduction and internal fixation) with EHA (elbow hemiarthroplasty) for distal humeral fractures in patients aged 50 years or above.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2019
CompletedFirst Posted
Study publicly available on registry
November 14, 2019
CompletedStudy Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2032
October 6, 2023
October 1, 2023
6.9 years
October 31, 2019
October 5, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Oxford Elbow Score (OES)
The OES is a 12-item patient-administrated questionnaire that measures the quality of life in patients with elbow disorder. There are three unidimensional domains: Elbow function, pain, and social-psychological status. Each question is answered on a 5-point scale with each question contributing equally to the total score.Thus, the total score ranges from 12-60, with 60 being the worst. For ease of presentation the score is converted to a scale from 0-48 with 48 being the best. The outcome can be interpreted based on a 48-point scale: 0 - 19 - poor; 20-29 - fair; 30-39 - good; and 40-48 - excellent. The Danish version which will be used in this study, has been translated and cultural adapted according to the guidelines by Guillemin, Bombardier and Beaton.
2 years after surgery.
Secondary Outcomes (4)
Mayo Elbow Performance Score (MEPS)
3 months after surgery and 1, 2, 5, and 10 years after surgery.
Pain severity score (VAS)
3 months after surgery and 1, 2, 5, and 10 years after surgery.
Range of motion
3 months after surgery and 1, 2, 5, and 10 years after surgery.
Patients satisfaction
3 months after surgery and 1, 2, 5, and 10 years after surgery.
Study Arms (2)
Elbow hemiarthroplasty
ACTIVE COMPARATORThe Latitude anatomical hemiarthroplasty (WRIGHT -Memphis, Tennessee) for distal humeral fractures.
Open reduction and internal fixation
ACTIVE COMPARATORDouble plating (Synthes - Switzerland and West Chester, Pennsylvania, United States) for distal humeral fractures.
Interventions
Latitude anatomical elbow hemiarthroplasty (WRIGHT -Memphis, Tennessee)
Double plating (Synthes - Switzerland and West Chester, Pennsylvania, United States)
Eligibility Criteria
You may qualify if:
- Distal humeral fracture AO/OTA type C2 or C3 confirmed by plain radiographs with 2 perpendicular views and CT scan.
- ASA score 1-3 and physically fit for surgery.
- Age of 50 years or above.
You may not qualify if:
- Patients unable to follow the rehabilitation protocol or answer the Danish questionnaires because of physical or cognitive inabilities as evaluated by the recruiting surgeon.
- Significant elbow osteoarthritis as evaluated by the recruiting surgeon based on plain radiographs and CT scan.
- Fractures that are older than 6 weeks.
- Other associated elbow fractures.
- Pathological fractures or relevant elbow pathology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Herlev and Gentofte University Hospital
Copenhagen, Denmark
Related Publications (1)
Al-Hamdani A, Rasmussen JV, Holtz K, Olsen BS. Elbow hemiarthroplasty versus open reduction and internal fixation for AO/OTA type 13 C2 and C3 fractures of distal humerus in patients aged 50 years or above: a randomized controlled trial. Trials. 2020 Jun 8;21(1):497. doi: 10.1186/s13063-020-04418-8.
PMID: 32513252DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Al-Hamdani, MD
Herlev and Gentofte University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical doctor, shoulder and elbow surgeon.
Study Record Dates
First Submitted
October 31, 2019
First Posted
November 14, 2019
Study Start
February 1, 2020
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2032
Last Updated
October 6, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share